| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 67028 |
Intravitreal injection of a pharmacologic agent |
4,897 |
4,008 |
$1.10M |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
910 |
750 |
$335K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,959 |
7,556 |
$206K |
| 92134 |
|
10,272 |
8,528 |
$203K |
| J9035 |
Injection, bevacizumab, 10 mg |
2,082 |
1,689 |
$158K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,746 |
2,685 |
$118K |
| 67228 |
|
429 |
347 |
$115K |
| 92235 |
|
1,968 |
1,966 |
$91K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
5,160 |
5,103 |
$81K |
| Q5128 |
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg |
142 |
115 |
$75K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
4,152 |
4,026 |
$73K |
| 92015 |
Determination of refractive state |
7,794 |
7,749 |
$69K |
| 92133 |
|
2,178 |
2,165 |
$36K |
| 92136 |
|
1,180 |
997 |
$34K |
| 92250 |
|
1,359 |
1,355 |
$32K |
| J7999 |
Compounded drug, not otherwise classified |
1,456 |
1,252 |
$24K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
213 |
213 |
$20K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
454 |
453 |
$16K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
162 |
161 |
$13K |
| 92002 |
|
295 |
295 |
$12K |
| J0178 |
Injection, aflibercept, 1 mg |
13 |
12 |
$10K |
| 92083 |
|
945 |
934 |
$10K |